Product Information
SUDOGEST 30 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.0776 per EA under NDC 00904672760. Its NADAC has been published 355 times since Dec 18, 2019.
The Low Outlier badge above means this manufacturer's average price in the Pseudoephedrine Hydrochloride market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
30 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904672760
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PSEUDOEPHEDRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
1/31/2019
Pharmacological Classes
Price Statistics
The NADAC for SUDOGEST 30 MG TABLET has been published 355 times since Dec 18, 2019, and over the history we have for it it has risen 43.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0776 per EA |
|---|---|
| All-time high | $0.0780 (Sep 16, 2026) |
| All-time low | $0.0458 (Jul 17, 2024) |
| 52-week high | $0.0780 |
| 52-week low | $0.0598 |
| Median price | $0.0540 |
| Average price | $0.0565 |
| Largest weekly change | +33.4% (Nov 22, 2023) |
| Weeks tracked | 355 |
| Tracking since | Dec 18, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Pseudoephedrine Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Pseudoephedrine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SUDOGEST 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SUDOGEST 30 MG TABLET, manufactured by Major Pharmaceuticals, is $0.0776 per EA (NDC 00904672760), effective Sep 30, 2026.
How has the price of SUDOGEST 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for SUDOGEST 30 MG TABLET has risen 43.5%. It has been tracked across 355 weekly CMS publications since Dec 18, 2019.
What are the highest and lowest recorded NADAC prices for SUDOGEST 30 MG TABLET?
Since Dec 18, 2019, the NADAC for SUDOGEST 30 MG TABLET has ranged from a low of $0.0458 (Jul 17, 2024) to a high of $0.0780 (Sep 16, 2026), with a median of $0.0540 per EA.
Are there cheaper alternatives to SUDOGEST 30 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of SUDOGEST 30 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SUDOGEST 30 MG TABLET?
SUDOGEST 30 MG TABLET (NDC 00904672760) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.